Friday, September 17, 2021

Medication Guide - 9/17/2021

 

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More

Drug Name Active Ingredient Form;Route Appl. No. Company Date
Descovy Emtricitabine; Tenofovir Alafenamide Fumarate TABLET;ORAL 208215 GILEAD SCIENCES INC 09/15/2021
Vimpat Lacosamide TABLET;ORAL 022253 UCB INC 09/15/2021
Vimpat Lacosamide SOLUTION;INTRAVENOUS 022254 UCB INC 09/15/2021
Vimpat Lacosamide SOLUTION;ORAL 022255 UCB INC 09/15/2021
Adempas Riociguat TABLET;ORAL 204819 BAYER HLTHCARE 09/10/2021
Conzip Tramadol Hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022370 CIPHER PHARMS INC 09/10/2021
Mayzent Siponimod Fumaric Acid TABLET;ORAL 209884 NOVARTIS 09/10/2021
Qdolo Tramadol Hydrochloride SOLUTION;ORAL 214044 ATHENA 09/10/2021
Ultracet Acetaminophen; Tramadol Hydrochloride TABLET;ORAL 021123 JANSSEN PHARMS 09/10/2021
Ultram Tramadol Hydrochloride TABLET;ORAL 020281 JANSSEN PHARMS 09/10/2021
Avsola Infliximab-Axxq INJECTABLE;INJECTION 761086 AMGEN INC 09/09/2021
Forteo Teriparatide SOLUTION;SUBCUTANEOUS 021318 LILLY 09/07/2021

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment